James Michael Billingsley
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Simian immunodeficiency virus | 8 | 2018 | 812 | 0.950 |
Why?
|
| Viral Regulatory and Accessory Proteins | 2 | 2018 | 151 | 0.620 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 5 | 2018 | 543 | 0.550 |
Why?
|
| SAIDS Vaccines | 2 | 2015 | 144 | 0.470 |
Why?
|
| Growth Hormone-Releasing Hormone | 3 | 2021 | 126 | 0.370 |
Why?
|
| Immunologic Memory | 3 | 2015 | 1377 | 0.310 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2018 | 4652 | 0.310 |
Why?
|
| Virus Replication | 6 | 2019 | 2457 | 0.250 |
Why?
|
| HIV Infections | 11 | 2022 | 17532 | 0.240 |
Why?
|
| Macaca mulatta | 8 | 2019 | 2341 | 0.230 |
Why?
|
| Interleukin-15 | 2 | 2022 | 186 | 0.230 |
Why?
|
| Interferon-alpha | 2 | 2018 | 910 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2018 | 4410 | 0.180 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2021 | 1802 | 0.170 |
Why?
|
| Viremia | 3 | 2018 | 727 | 0.160 |
Why?
|
| Growth Substances | 1 | 2021 | 759 | 0.160 |
Why?
|
| Lentiviruses, Primate | 1 | 2018 | 6 | 0.150 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2018 | 56 | 0.150 |
Why?
|
| Host Specificity | 1 | 2018 | 56 | 0.150 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 149 | 0.150 |
Why?
|
| Gene Expression | 2 | 2020 | 7585 | 0.140 |
Why?
|
| Gene Products, env | 1 | 2018 | 250 | 0.140 |
Why?
|
| HIV-1 | 5 | 2020 | 6948 | 0.130 |
Why?
|
| Lymphocyte Activation | 5 | 2018 | 5502 | 0.130 |
Why?
|
| Blood Proteins | 1 | 2021 | 1194 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2015 | 12159 | 0.120 |
Why?
|
| Interferon Type I | 1 | 2018 | 568 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2019 | 1040 | 0.110 |
Why?
|
| Adenoviridae | 1 | 2018 | 1093 | 0.110 |
Why?
|
| Receptors, IgE | 2 | 2005 | 375 | 0.110 |
Why?
|
| Th17 Cells | 1 | 2019 | 790 | 0.100 |
Why?
|
| Pluripotent Stem Cells | 1 | 2019 | 808 | 0.100 |
Why?
|
| Huntington Disease | 1 | 2019 | 1147 | 0.100 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 1189 | 0.100 |
Why?
|
| Viral Load | 6 | 2019 | 3385 | 0.100 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1560 | 0.100 |
Why?
|
| Astrocytes | 1 | 2019 | 1351 | 0.100 |
Why?
|
| T-Lymphocytes | 3 | 2018 | 10263 | 0.090 |
Why?
|
| Iron | 1 | 2020 | 1812 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1752 | 0.090 |
Why?
|
| Receptors, CXCR5 | 2 | 2022 | 88 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2019 | 11657 | 0.080 |
Why?
|
| Interleukin-12 | 2 | 2022 | 581 | 0.080 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 1787 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2018 | 3401 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3942 | 0.070 |
Why?
|
| Chromatin | 1 | 2019 | 2980 | 0.070 |
Why?
|
| Proteomics | 1 | 2021 | 3915 | 0.070 |
Why?
|
| Calcium Channels | 2 | 2007 | 622 | 0.070 |
Why?
|
| Placebos | 2 | 2021 | 1659 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2018 | 3070 | 0.060 |
Why?
|
| Ion Transport | 1 | 2006 | 322 | 0.060 |
Why?
|
| Animals | 13 | 2021 | 168939 | 0.060 |
Why?
|
| Anti-HIV Agents | 2 | 2019 | 4561 | 0.060 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2005 | 282 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9528 | 0.050 |
Why?
|
| Mast Cells | 2 | 2007 | 1405 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 1999 | 975 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 9244 | 0.050 |
Why?
|
| Killer Cells, Natural | 2 | 2022 | 2209 | 0.050 |
Why?
|
| Lymph Nodes | 2 | 2022 | 3468 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 1110 | 0.040 |
Why?
|
| Sumoylation | 1 | 2020 | 83 | 0.040 |
Why?
|
| Administration, Intravaginal | 1 | 2019 | 149 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 2019 | 270 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2018 | 2177 | 0.040 |
Why?
|
| Calcium | 3 | 2007 | 5783 | 0.040 |
Why?
|
| Macaca | 1 | 2020 | 413 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10863 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2005 | 1495 | 0.040 |
Why?
|
| Hepatitis | 1 | 2020 | 226 | 0.040 |
Why?
|
| Signal Transduction | 5 | 2019 | 23618 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 2018 | 115 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 501 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2020 | 572 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2021 | 637 | 0.040 |
Why?
|
| Virus Latency | 1 | 2020 | 359 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2021 | 12430 | 0.030 |
Why?
|
| Hormones | 1 | 2020 | 866 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2006 | 5388 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 630 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2005 | 1168 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2019 | 1587 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2018 | 18986 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 632 | 0.030 |
Why?
|
| Jejunum | 1 | 2017 | 474 | 0.030 |
Why?
|
| Ligands | 1 | 2021 | 3274 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3600 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2005 | 4033 | 0.030 |
Why?
|
| Virulence | 1 | 2018 | 1294 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Cell Line | 3 | 2020 | 15564 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2018 | 13411 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2221 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2020 | 1934 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 895 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2014 | 434 | 0.020 |
Why?
|
| Homosexuality, Male | 1 | 2020 | 1342 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2039 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 2586 | 0.020 |
Why?
|
| Female | 7 | 2021 | 396532 | 0.020 |
Why?
|
| Cell Survival | 1 | 2021 | 5749 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2020 | 4143 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 18329 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10451 | 0.020 |
Why?
|
| Tyrosine | 2 | 2005 | 1425 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 3511 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2747 | 0.020 |
Why?
|
| Humans | 15 | 2022 | 766812 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2006 | 7869 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 11924 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2493 | 0.020 |
Why?
|
| Cell Movement | 1 | 2021 | 5204 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 2952 | 0.020 |
Why?
|
| Gene Products, gag | 2 | 1999 | 317 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6507 | 0.020 |
Why?
|
| HIV Core Protein p24 | 2 | 1999 | 245 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2329 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2007 | 276 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8728 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2018 | 9358 | 0.020 |
Why?
|
| Vaccination | 1 | 2018 | 3435 | 0.020 |
Why?
|
| Passive Cutaneous Anaphylaxis | 1 | 2005 | 31 | 0.020 |
Why?
|
| Vitronectin | 1 | 2005 | 40 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 2815 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2017 | 3079 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 4787 | 0.010 |
Why?
|
| Liver | 1 | 2020 | 7571 | 0.010 |
Why?
|
| Protein Kinase C-delta | 1 | 2005 | 115 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4356 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 2004 | 166 | 0.010 |
Why?
|
| U937 Cells | 1 | 2004 | 260 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2007 | 940 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 7612 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 874 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 924 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 10384 | 0.010 |
Why?
|
| Phosphorylation | 2 | 2005 | 8310 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 59939 | 0.010 |
Why?
|
| Glutamine | 1 | 2006 | 575 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2007 | 1968 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22351 | 0.010 |
Why?
|
| Melanoma | 1 | 2021 | 5702 | 0.010 |
Why?
|
| Male | 5 | 2021 | 364154 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 928 | 0.010 |
Why?
|
| Cell Division | 2 | 1999 | 4473 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2004 | 539 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2005 | 893 | 0.010 |
Why?
|
| Fibronectins | 1 | 2005 | 722 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 4168 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2006 | 1181 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2005 | 1206 | 0.010 |
Why?
|
| Serotonin | 1 | 2005 | 1045 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 17609 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29959 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3759 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 5022 | 0.010 |
Why?
|
| Mice | 2 | 2021 | 81898 | 0.010 |
Why?
|
| HLA-A2 Antigen | 1 | 1999 | 207 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3093 | 0.010 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 1997 | 95 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1999 | 736 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 223305 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2006 | 2591 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1999 | 880 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 223267 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2005 | 2448 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 1999 | 827 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 2426 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1999 | 1838 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 2902 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2887 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1997 | 1352 | 0.010 |
Why?
|
| Chemokines | 1 | 1997 | 963 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 88902 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 7438 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 1999 | 1337 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14473 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1999 | 2606 | 0.010 |
Why?
|
| Disease Progression | 2 | 1999 | 13642 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1997 | 3157 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 23717 | 0.000 |
Why?
|
| Aged | 1 | 2021 | 171344 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1997 | 6306 | 0.000 |
Why?
|
| Peptides | 1 | 1999 | 4347 | 0.000 |
Why?
|
| Cohort Studies | 2 | 1999 | 41706 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5143 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1999 | 14762 | 0.000 |
Why?
|
| Phenotype | 1 | 1999 | 16722 | 0.000 |
Why?
|
| Time Factors | 1 | 1999 | 40149 | 0.000 |
Why?
|
| Mutation | 1 | 1999 | 30214 | 0.000 |
Why?
|